arrow
P

Philip A. Harris

Mayo Clinic
H指数:40
被引数:7,226

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

RIPK1 Mediates TNF-Induced Intestinal Crypt Apoptosis During Chronic NF-κB Activation

RIPK1在慢性nf-κb激活过程中介导TNF诱导的肠隐窝凋亡

2020-01-0134
OAAI
Identification of a RIP1 Kinase Inhibitor Clinical Candidate (GSK3145095) for the Treatment of Pancreatic Cancer
2019-05-0978
OAAI
Discovery and Lead-Optimization of 4,5-Dihydropyrazoles as Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) Kinase
2019-04-2360
OAAI
RIPK1 and Caspase-8 Ensure Chromosome Stability Independently of Their Role in Cell Death and Inflammation

RIPK1和Caspase-8确保染色体稳定性,而与它们在细胞死亡和炎症中的作用无关

2019-02-0156
OAAI
Elevated A20 promotes TNF-induced and RIPK1-dependent intestinal epithelial cell death

升高的A20促进TNF诱导和RIPK1-dependent肠上皮细胞死亡

2018-09-1269
OAAI
Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases
2017-02-10427
PREAI
DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors
2016-02-23259
OAAI
Caspase-8 and RIP kinases regulate bacteria-induced innate immune responses and cell death

Caspase-8和RIP激酶调节细菌诱导的先天免疫反应和细胞死亡

2014-05-05278
OAAI
Discovery of Small Molecule RIP1 Kinase Inhibitors for the Treatment of Pathologies Associated with Necroptosis
2013-11-06147
OAAI
Discovery of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide (pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor
2008-07-12342
PREAI